Gut Microbiota Modulation for Immunotherapy Resensitization in Advanced Renal Cell Carcinoma
Clinical trial NCT07611825 · RECRUITING
Trial details
- NCT number
- NCT07611825
- Sponsor
- Jinling Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-12-31
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.